PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
The Korean Journal of Internal Medicine10.3904/kjim.2018.09720193451125-1135Long-term rivaroxaban for the treatment of acute venous thromboembolism in patients with active cancer in a prospective multicenter trialHo-Young Yhim, Won-Il Choi, Sung-Hyun Kim, Seung-Hyun Nam, Kyoung Ha Kim, Yeung-Chul Mun, Doyeun Oh, Hun-Gyu Hwang, Keun-Wook Lee, Eun-Kee Song, Yong Shik Kwon, Soo-Mee Banghttp://kjim.org/upload/kjim-2018-097.pdf, http://kjim.org/journal/view.php?doi=10.3904/kjim.2018.097, http://kjim.org/upload/kjim-2018-097.pdf
Chest10.1378/chest.134.4_meetingabstracts.p380042008134438PAN EVALUATION OF THE LONG-TERM TREATMENT OF VENOUS THROMBOEMBOLISM IN HOSPITALIZED CANCER PATIENTSJian Wang, Vicky Tagalakishttps://api.elsevier.com/content/article/PII:S0012369216450427?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0012369216450427?httpAccept=text/plain
Fundamental & Clinical Pharmacology10.1111/j.1472-8206.2011.00980.x201126133-38Rivaroxaban for the prevention and treatment of venous thromboembolismAlexander G.G. Turpiehttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1472-8206.2011.00980.x
BMC Cancer10.1186/1471-2407-13-2842013131CATCH: a randomised clinical trial comparing long-term tinzaparin versus warfarin for treatment of acute venous thromboembolism in cancer patientsAgnes YY Lee, Rupert Bauersachs, Mette S Janas, Mikala F Jarner, Pieter W Kamphuisen, Guy Meyer, Alok A Khoranahttp://link.springer.com/content/pdf/10.1186/1471-2407-13-284.pdf, http://link.springer.com/article/10.1186/1471-2407-13-284/fulltext.html, http://link.springer.com/content/pdf/10.1186/1471-2407-13-284
Thrombosis Research10.1016/j.thromres.2018.02.1282018164S240Risk of recurrence and bleeding with Rivaroxaban among patients with venous thromboembolism and active cancerM. Søgaard, P.B. Nielsen, F. Skjøth, J.N. Kjældgaard, T.B. Larsenhttps://api.elsevier.com/content/article/PII:S0049384818301932?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0049384818301932?httpAccept=text/plain
Respiration10.1159/0004998952019983203-211A Retrospective Study on Efficacy and Safety of Rivaroxaban and Dalteparin for Long-Term Treatment of Venous Thromboembolism in Patients with Lung CancerJang Ho Lee, Dong-gon Hyun, Chang Min Choi, Jae Cheol Lee, Woo Sung Kim, Yeon-Mok Oh, Sang-Do Lee, Jae Seung Leehttps://www.karger.com/Article/Pdf/499895, https://www.karger.com/Article/Pdf/499895
Thrombosis Research10.1016/j.thromres.2018.02.0552018164S204Long-term treatment bemiparin in patients with Cancer-Associated Venous Thromboembolism. ELEBAMA studyP. Pascual Elena, A. Rebollo Maite, P. Vidal Joan, R. Palmer Elena, D. Santasusana Perehttps://api.elsevier.com/content/article/PII:S0049384818301208?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0049384818301208?httpAccept=text/plain
Internal Medicine Journal10.1111/j.1445-5994.2011.02448.x20114111769-775Systematic screening for occult cancer in elderly patients with venous thromboembolism: a prospective studyV. Rieu, S. Chanier, P. Philippe, M. Ruivardhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1445-5994.2011.02448.x
Oncology Research and Treatment10.1159/0003808712015384174-180Treatment of Venous Thromboembolism in Ambulatory Cancer Patients in Germany: A Prospective Non-Interventional StudyAxel Matzdorff, Holger Schilling, Bettina Ledighttps://www.karger.com/Article/Pdf/380871, https://www.karger.com/Article/Pdf/380871
Journal of Thrombosis and Thrombolysis10.1007/s11239-014-1102-52014392155-165Indirect comparison of dabigatran, rivaroxaban, apixaban and edoxaban for the treatment of acute venous thromboembolismSimon Mantha, Jack Ansellhttp://link.springer.com/content/pdf/10.1007/s11239-014-1102-5.pdf, http://link.springer.com/article/10.1007/s11239-014-1102-5/fulltext.html, http://link.springer.com/content/pdf/10.1007/s11239-014-1102-5